Oriental Trimex Limited (NSE:ORIENTALTL)
India flag India · Delayed Price · Currency is INR
10.20
-0.11 (-1.07%)
Aug 13, 2025, 3:30 PM IST

Oncternal Therapeutics Revenue

Oriental Trimex had revenue of 35.10M INR in the quarter ending June 30, 2025, with 546.11% growth. This brings the company's revenue in the last twelve months to 239.86M, up 414.00% year-over-year. In the fiscal year ending March 31, 2025, Oriental Trimex had annual revenue of 210.20M with 372.97% growth.

Revenue (ttm)
239.86M
Revenue Growth
+414.00%
P/S Ratio
3.10
Revenue / Employee
14.99M
Employees
16
Market Cap
744.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025210.20M165.76M372.97%
Mar 31, 202444.44M-42.70M-49.00%
Mar 31, 202387.15M-98.18M-52.98%
Mar 31, 2022185.32M2.81M1.54%
Mar 31, 2021182.51M-565.81M-75.61%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition